# Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease

> **NCT01012414** · PHASE3 · TERMINATED · sponsor: **Thomas Jefferson University** · enrollment: 10 (actual)

## Conditions studied

- Coronary Artery Disease
- Chronic Kidney Disease
- Hypovitaminosis D
- Secondary Hyperparathyroidism

## Interventions

- **DRUG:** paricalcitol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01012414
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Futility in enrollment as of May 31, 2011
- **Last updated:** 2014-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01012414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01012414, "Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT01012414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*